439 results on '"Thomas T. MacDonald"'
Search Results
302. Suppressor T cells, rebranded as regulatory T cells, emerge from the wilderness bearing surface markers
303. Correction: Corrigendum: The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease
304. Protective Effects of Timp-3 on Gut Inflammation
305. OC.06.3: EVIDENCE FOR AN ANTI-FIBROGENIC ROLE OF ANANDAMIDE IN CROHN'S DISEASE
306. OC.05.7: PROTECTIVE EFFECTS OF TIMP-3 ON GUT INFLAMMATION
307. OC.06.7: EFFECT OF MATRIX METALLOPROTEINASE (MMP)-3, -8, -10 AND -12 ON THE STRUCTURE AND FUNCTION OF ANTI-TUMOR NECROSIS FACTOR-ALPHA AGENTS IN INFLAMMATORY BOWEL DISEASE
308. Aryl Hydrocarbon Receptor-Induced Signals Up-regulate IL-22 Production and Inhibit Inflammation in the Gastrointestinal Tract
309. Cyclosporin A enhances T cell-mediated induction of E-selectin
310. Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea
311. Contributors
312. The worm turns on Helicobacter pylori
313. M1803 Differential Degradation of Anti-Tumor Necrosis Factor-α Agents by Matrix Metalloproteinase-12 in Inflammatory Bowel Disease
314. S28 T-regulatory cells in Crohn's disease patients treated with infliximab
315. P.63 INTERLEUKIN (IL)-17A BUT NOT IL-17E IS PROFIBROTIC IN CROHN'S DISEASE
316. OC.01.1 DIFFERENTIAL DEGRADATION OF ANTI-TUMOR NECROSIS FACTOR-ALPHA AGENTS BY MATRIX METALLOPROTEINASE-12 IN INFLAMMATORY BOWEL DISEASE
317. P.59 HIGH IFN-GAMMA EXPRESSION IS REQUIRED FOR TUMOR PROTECTION IN A MODEL OF COLITIS-ASSOCIATED COLORECTAL CANCER
318. Direct in vitro infection of human intestine with HIV-1
319. Activation of lamina propria T cells induces crypt epithelial proliferation and goblet cell depletion in cultured human fetal colon
320. Immunology of Gastrointestinal Disease
321. O11 CURCUMIN SUPPRESSES P38 MAPK ACTIVATION, REDUCES IL-1BETA AND MMP-3, AND ENHANCES IL-10 EXPRESSION IN THE MUCOSA OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
322. 52 Smad7 Expression in T Cells Protects from Colitis-Associated Colorectal Cancer
323. 241 Interleukin (IL)-25 Inhibits IL-12 Production and TH1 Cell-Driven Inflammation in the Gut
324. M2021 Increased Expression of Interleukin 17 in Celiac Disease Mucosa
325. S1731 Differential Regulation of Interleukin-17 and Interferon-γ Production in Inflammatory Bowel Disease
326. SMAD7 EXPRESSION IN T CELLS PROTECTS FROM COLITIS-ASSOCIATED COLORECTAL CANCER
327. INTERLEUKIN (IL)-25 INHIBITS IL-12 PRODUCTION AND TH1 CELL-DRIVEN INFLAMMATION IN THE GUT
328. P294 - Control of interleukin-17 production in inflammatory bowel disease
329. P270 - Fibroblast activation protein expression in Crohn's disease strictures
330. P267 - Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression
331. 2 - Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits Th1 cytokine production and T-box transcription factor T-bet in inflammatory bowel disease
332. Histopathology and immunohistochemistry of the caecum in children with the Trichuris dysentery syndrome
333. Regulation of Matrix Metalloproteinases in Human Intestinal Mucosa
334. Professor Anne Ferguson (Anne Collee) 1941-1998
335. 23 Autocrine Regulation of Interleukin-21 Production in Human Peripheral Blood and Intestinal T Lymphocytes
336. W1168 A Key Role for the Endocannabinoid System in Dampening T Helper Cell Type 1 Response in Inflammatory Bowel Disease
337. W1230 CD4+Cd25highfoxp3+ T-Regulatory Cells in Crohn's Disease Patients Treated with Infliximab
338. W1167 Activation and Modulation of the MAP Kinase Pathway in IBD
339. S1719 Regulation of Gut Inflammation and TH17 Cell Response By Interleukin-21
340. T1268 Mucosal Addressin Cell Adhesion Molecule-1 in Celiac Disease
341. P272 EFFECT OF INFLIXIMAB ON CD4+CD25HIGHFOXP3+ T-REGULATORY CELLS IN CROHN'S DISEASE
342. P256 THE ENDOCANNABINOID SYSTEM IN INFLAMMATORY BOWEL DISEASE
343. Gamma/delta T cells in the gut epithelium
344. Ontogeny of the mucosal immune response
345. Gut immunology
346. Changes in the rate of crypt epithelial cell proliferation and mucosal morphology induced by a T-cell-mediated response in human small intestine
347. Increased expression of laminin/collagen receptor (VLA-1) on epithelium of inflamed human intestine
348. Advances in Mucosal Immunology
349. Activated T cells and macrophages in the intestinal mucosa of children with inflammatory bowel disease
350. P027 FUNCTIONAL MODULATION OF CROHN'S DISEASE MYOFIBROBLASTS BY ANTI-TNF ANTIBODIES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.